Moleculin Biotech, Inc. (MBRX) shareholders
Close on Nov 17, 2026Market cap $133.03MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Klemp Walter V | 2,070,761 | 9.90% | 13D (active) | Aug 19, 2026 |
| CVI Investments, Inc. Joint filing with Heights Capital Management, Inc. (9.90%) | 1,863,377 | 9.90% | 13G (passive) | Jul 31, 2026 |
| Foster Jonathan P. | 1,288,207 | 6.30% | 13D (active) | Aug 19, 2026 |
| Steven Boyd Joint filing with Armistice Capital, LLC (9.99%) | 339,767 | 9.99% | 13G (passive) amendment | Dec 31, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of MBRX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 2,363 | 0.01% | $131.83K | +746 | 0.00% |
| Vanguard Capital Management LLC | 2,111 | 0.01% | $117.78K | +1,418 | 0.00% |
| Vanguard Fiduciary Trust Co | 1,494 | 0.01% | $83.37K | +1,190 | 0.00% |
| XTX Topco Ltd | 1,147 | 0.01% | $64.01K | New | 0.00% |
| Morgan Stanley | 1,002 | 0.01% | $55.90K | +1,000 | 0.00% |
| Rockefeller Capital Management L.P. | 750 | 0.00% | $41.85K | +529 | 0.00% |
| Tower Research Capital LLC (TRC) | 175 | 0.00% | $9.80K | +83 | 0.00% |
| Citigroup Inc | 134 | 0.00% | $7.46K | New | 0.00% |
| Barclays PLC | 31 | 0.00% | $1.73K | New | 0.00% |
| BlackRock, Inc. | 25 | 0.00% | $1.37K | – | 0.00% |
| EFG International AG | 22 | 0.00% | $1.21K | – | 0.00% |
| Jones Financial Companies Lllp | 18 | 0.00% | $1.18K | New | 0.00% |
| Wells Fargo & Company/Mn | 10 | 0.00% | $558 | New | 0.00% |
| Newbridge Financial Services Group, Inc. | 6 | 0.00% | $318 | – | 0.00% |
| SBI Securities Co., Ltd. | 2 | 0.00% | $123 | – | 0.00% |
| Danske Bank A/S | 0 | 0.00% | $6 | – | 0.00% |
| Osaic Holdings, Inc. | 0 | 0.00% | $2 | – | 0.00% |
| CVA Family Office, LLC | 0 | 0.00% | $3 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 18 | 0M | 0.0% | 5 / 6 | 0 / 7 | 0M | 0M |
| Q1 2026 | 20 | 0M | 0.0% | 7 / 4 | 1 / 3 | 0M | 0M |
| Q4 2025 | 17 | 0M | 0.0% | 17 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
5 funds held MBRX in Q2 2026, 48% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of MBRX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 28,274 | 0.15% | $78.88K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 21,901 | 0.11% | $61.10K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 4,484 | 0.02% | $12.51K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 3,142 | 0.02% | $8.77K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 915 | 0.00% | $2.55K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Walter V. Klemp | CEO and President, Director | 1,111,203 | 5.71% | Nov 6, 2026 |
| Jonathan P. Foster | Chief Financial Officer | 20,291 | 0.10% | Nov 6, 2026 |
| Donald H. Picker | Chief Science Officer | 560,718 | 2.88% | Nov 6, 2026 |
| John M. Climaco | Director | – | – | Nov 14, 2025 |
| Michael D. Cannon | Director | – | – | Nov 14, 2025 |
| Robert E. George | Director | 14,660 | 0.08% | Nov 14, 2025 |
| Elizabeth Cermak | Director | – | – | Nov 14, 2025 |
| Joy Yan | Director | – | – | Nov 14, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Donald H. Picker Chief Science Officer | Nov 4, 2026 | Tax withholding | −4 | $8.46 | $34 | 8,718 |
| Donald H. Picker Chief Science Officer | Nov 4, 2026 | Option exercise | +17 | – | – | 8,722 |
| Jonathan P. Foster Chief Financial Officer | Nov 4, 2026 | Tax withholding | −10 | $8.46 | $85 | 20,291 |
| Jonathan P. Foster Chief Financial Officer | Nov 4, 2026 | Option exercise | +41 | – | – | 20,301 |
| Walter V. Klemp CEO and President, Director | Nov 4, 2026 | Tax withholding | −14 | $8.46 | $118 | 36,203 |
| Walter V. Klemp CEO and President, Director | Nov 4, 2026 | Option exercise | +57 | – | – | 36,217 |
| Walter V. Klemp CEO and President, Director | Oct 15, 2026 | Tax withholding | −48,659 | $0.37 | $18.01K | 723,181 |
| Walter V. Klemp CEO and President, Director | Oct 15, 2026 | Option exercise | +207,500 | – | – | 771,840 |
| Jonathan P. Foster Chief Financial Officer | Oct 15, 2026 | Tax withholding | −30,485 | $0.37 | $11.28K | 405,188 |
| Jonathan P. Foster Chief Financial Officer | Oct 15, 2026 | Option exercise | +130,000 | – | – | 435,673 |
| Donald H. Picker Chief Science Officer | Aug 3, 2026 | Buy | +173,333 | – | – | 174,086 |
| Jonathan P. Foster Chief Financial Officer | Aug 3, 2026 | Buy | +293,333 | – | – | 305,673 |
| Walter V. Klemp CEO and President, Director | Aug 3, 2026 | Buy | +533,333 | – | – | 564,340 |
| Jonathan P. Foster Chief Financial Officer | Jun 22, 2026 | Tax withholding | −41 | $3.12 | $128 | 12,340 |
| Jonathan P. Foster Chief Financial Officer | Jun 22, 2026 | Option exercise | +174 | – | – | 12,381 |
| Walter V. Klemp CEO and President, Director | Jun 22, 2026 | Tax withholding | −88 | $3.12 | $275 | 31,007 |
| Walter V. Klemp CEO and President, Director | Jun 22, 2026 | Option exercise | +360 | – | – | 31,088 |
| Donald H. Picker Chief Science Officer | Jun 22, 2026 | Option exercise | +71 | – | – | 774 |
| Donald H. Picker Chief Science Officer | Jun 22, 2026 | Tax withholding | −21 | $3.12 | $66 | 753 |
| Jonathan P. Foster Chief Financial Officer | Jun 20, 2026 | Tax withholding | −31 | $2.88 | $89 | 12,207 |
| Jonathan P. Foster Chief Financial Officer | Jun 20, 2026 | Option exercise | +109 | – | – | 12,238 |
| Walter V. Klemp CEO and President, Director | Jun 20, 2026 | Option exercise | +150 | – | – | 30,765 |
| Walter V. Klemp CEO and President, Director | Jun 20, 2026 | Tax withholding | −37 | $2.88 | $107 | 30,728 |
| Donald H. Picker Chief Science Officer | Jun 20, 2026 | Tax withholding | −13 | $2.88 | $37 | 703 |
| Donald H. Picker Chief Science Officer | Jun 20, 2026 | Option exercise | +44 | – | – | 716 |
| Jonathan P. Foster Chief Financial Officer | Nov 4, 2025 | Option exercise | −5,023 | $0.50 | $2.51K | 303,189 |
| Jonathan P. Foster Chief Financial Officer | Nov 4, 2025 | Option exercise | +20,625 | – | – | 308,212 |
| Donald H. Picker Chief Science Officer | Nov 4, 2025 | Option exercise | +8,750 | – | – | 18,902 |
| Donald H. Picker Chief Science Officer | Nov 4, 2025 | Tax withholding | −2,131 | $0.50 | $1.07K | 16,771 |
| Walter V. Klemp CEO and President, Director | Nov 4, 2025 | Tax withholding | −7,001 | $0.50 | $3.50K | 765,356 |
| Walter V. Klemp CEO and President, Director | Nov 4, 2025 | Option exercise | +28,750 | – | – | 772,357 |
| Walter V. Klemp CEO and President, Director | Jun 23, 2025 | Buy | +675,675 | $0.37 | $250.00K | 743,607 |
| Jonathan P. Foster Chief Financial Officer | Jun 23, 2025 | Buy | +270,270 | $0.37 | $100.00K | 287,587 |
| Walter V. Klemp CEO and President, Director | Jun 22, 2025 | Option exercise | +8,990 | – | – | 70,122 |
| Walter V. Klemp CEO and President, Director | Jun 22, 2025 | Tax withholding | −2,190 | $0.27 | $591 | 67,932 |
| Jonathan P. Foster Chief Financial Officer | Jun 22, 2025 | Option exercise | +4,328 | – | – | 18,371 |
| Jonathan P. Foster Chief Financial Officer | Jun 22, 2025 | Tax withholding | −1,054 | $0.27 | $285 | 17,317 |
| Donald H. Picker Chief Science Officer | Jun 22, 2025 | Option exercise | +1,766 | – | – | 10,582 |
| Donald H. Picker Chief Science Officer | Jun 22, 2025 | Tax withholding | −430 | $0.27 | $116 | 10,152 |
| Walter V. Klemp CEO and President, Director | Jun 20, 2025 | Tax withholding | −914 | $0.27 | $247 | 61,132 |
| Walter V. Klemp CEO and President, Director | Jun 20, 2025 | Option exercise | +3,750 | – | – | 62,046 |
| Jonathan P. Foster Chief Financial Officer | Jun 20, 2025 | Tax withholding | −661 | $0.27 | $178 | 14,043 |
| Jonathan P. Foster Chief Financial Officer | Jun 20, 2025 | Option exercise | +2,711 | – | – | 14,704 |
| Donald H. Picker Chief Science Officer | Jun 20, 2025 | Tax withholding | −263 | $0.27 | $71 | 8,816 |
| Donald H. Picker Chief Science Officer | Jun 20, 2025 | Option exercise | +1,078 | – | – | 9,079 |
| Walter V. Klemp CEO and President, Director | Jun 16, 2025 | Tax withholding | −406 | $0.69 | $280 | 58,296 |
| Walter V. Klemp CEO and President, Director | Jun 16, 2025 | Option exercise | +1,667 | – | – | 58,702 |
| Jonathan P. Foster Chief Financial Officer | Jun 16, 2025 | Option exercise | +833 | – | – | 12,196 |
| Jonathan P. Foster Chief Financial Officer | Jun 16, 2025 | Tax withholding | −203 | $0.69 | $140 | 11,993 |
| Walter V. Klemp CEO and President, Director | Jul 2, 2024 | Option exercise | +982 | – | – | 57,275 |
| Walter V. Klemp CEO and President, Director | Jul 2, 2024 | Tax withholding | −240 | $3.57 | $857 | 57,035 |
| Walter V. Klemp CEO and President, Director | Jun 22, 2024 | Option exercise | +8,990 | – | – | 58,483 |
| Walter V. Klemp CEO and President, Director | Jun 22, 2024 | Tax withholding | −2,190 | $3.74 | $8.19K | 56,293 |
| Jonathan P. Foster Chief Financial Officer | Jun 22, 2024 | Option exercise | +4,329 | – | – | 12,416 |
| Jonathan P. Foster Chief Financial Officer | Jun 22, 2024 | Tax withholding | −1,053 | $3.74 | $3.94K | 11,363 |
| Donald H. Picker Chief Science Officer | Jun 22, 2024 | Tax withholding | +524 | $3.74 | $1.96K | 8,001 |
| Donald H. Picker Chief Science Officer | Jun 22, 2024 | Option exercise | +1,766 | – | – | 8,525 |
| Walter V. Klemp CEO and President, Director | Jun 20, 2024 | Tax withholding | −914 | $3.78 | $3.45K | 49,493 |
| Walter V. Klemp CEO and President, Director | Jun 20, 2024 | Option exercise | +3,750 | – | – | 50,407 |
| Donald H. Picker Chief Science Officer | Jun 20, 2024 | Tax withholding | −320 | $3.78 | $1.21K | 6,759 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Moleculin Biotech's stock actually held short. Settlement fails (shares not delivered on time) peaked at 49,019 shares on Sep 23, 2026 over the last 90 days.
See a number that looks wrong?